NDC 68026-863-30 - La Prairie Concealer-Foundation Sunscreen SPF 15 WARM LINEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68026-863
- Requested NDC
- 68026-863-30
- Package NDCs from labels
- 68026-863-30
- Manufacturer
- La Prairie, Inc.
- Effective date
- 2025-02-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| La Prairie Concealer-Foundation Sunscreen SPF 15 - WARM LINEN | La Prairie, Inc. | 2025-02-21 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68026-863-30 | La Prairie Concealer-Foundation Sunscreen SPF 15 WARM LINEN | 30 mL in 1 BOTTLE | CREAM | 30 mL | 60 mg in 1mL | 3 |
| 68026-863-30 | La Prairie Concealer-Foundation Sunscreen SPF 15 WARM LINEN | 1 in 1 BOX | CREAM | 60 mg in 1mL | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ray Defense Broad Spectrum SPF 30 | AVOBENZONE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | Bioelements | 807db1ff-a64a-44e4-a786-f88cd4518433 | 2026-10-27 | Warnings | 4Y5P7MUD51 |
| SPF 50 Face Sunscreen Bioelements | AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | Bioelements, Inc | 981c7b3c-d7d6-483d-bf32-10d526be5b3f | 2026-10-27 | Warnings | 4Y5P7MUD51 |
| TrueLipids Boo-Boo and Bum Balm CL MD | WHITE PETROLATUM | Claridei Laboratories, Inc. | 27bf896e-5614-42f3-e063-6394a90ac323 | 2026-10-27 | Warnings | 4T6H12BN9U |
| TrueLipids Relieve and Protect CL MD | WHITE PETROLATUM | Claridei Laboratories, Inc. | 27c0af9b-f397-dec3-e063-6394a90aed8b | 2026-10-27 | Warnings | 4T6H12BN9U |
| Truelipids TrueLips Lip Balm CL MD | WHITE PETROLATUM | Claridei Laboratories, Inc. | 27c155dc-f194-6750-e063-6394a90a20b1 | 2026-10-27 | Warnings | 4T6H12BN9U |
| QUALITY CHOICE Original Flavor | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | CHAIN DRUG MARKETING ASSOCIATION INC. | a699b830-6400-4af9-9810-5eda79157333 | 2026-10-27 | Warnings | 5QB0T2IUN0 |
| 5% Minoxidil | 5% MINOXIDIL | Guangzhou Yanxi Biotechnology Co., Ltd | 5d733f78-9298-5abc-e063-6394a90a9480 | 2026-10-26 | Warnings | 6SO6U10H04 |
| 5% Minoxidil Hair Regrowth Treatment | MINOXIDIL | Shenzhen Fanyi Era Technology Co., Ltd | 5eb94759-3abc-c516-e063-6294a90af770 | 2026-10-26 | Warnings | 6SO6U10H04 |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2026-10-26 | Warnings | PDC6A3C0OX |
| Normal Salt | SODIUM CHLORIDE | GRAXCELL PHARMACEUTICAL, LLC | f3f09817-8a38-4aa1-956b-69d9cf695074 | 2026-10-26 | Warnings | 451W47IQ8X |
| Maximum Strength Gas Relief | MAXIMUM STRENGTH GAS RELIEF | Famora Inc | 8ee9549d-64dd-41cd-8a4a-93e9e8f4733e | 2026-10-26 | Warnings | 92RU3N3Y1O |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2026-10-26 | Warnings | 4T6H12BN9U PDC6A3C0OX |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | WHITE PETROLATUM, LANOLIN | Scope Health Inc | c1991caa-51b9-13d1-e053-2995a90a1293 | 2026-10-25 | Warnings | 4T6H12BN9U |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.